Ute Essner
Hamburg, HH 22339, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Patient-reported benefits from nabiximols treatment in multiple sclerosis-related spasticity exceed conventional measures.
Journal: Neurodegenerative disease management
Published: February 06, 2024
Efficacy and safety/tolerability of pridinol: a meta-analysis of double-blind, randomized, placebo-controlled trials in adult patients with muscle pain.
Journal: Current medical research and opinion
Published: May 03, 2022
Effects of SativexⓇ on cognitive function in patients with multiple sclerosis: A systematic review and meta-analysis.
Journal: Multiple sclerosis and related disorders
Published: January 05, 2022
Prevalence of drug-induced constipation and severity of associated biopsychosocial effects in patients with nonmalignant pain: a cross-sectional review of depersonalized data from the German Pain e-Registry.
Journal: Current medical research and opinion
Published: October 07, 2021
Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry.
Journal: Journal of pain research
Published: September 29, 2021
Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry.
Journal: Pain medicine (Malden, Mass.)
Published: May 06, 2021
Nabiximols in Chronic Neuropathic Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials.
Journal: Pain medicine (Malden, Mass.)
Published: February 09, 2021
Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
Journal: The International journal of neuroscience
Published: February 18, 2020
Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry.
Journal: Journal of pain research
Published: October 25, 2018
Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies.
Journal: Journal of central nervous system disease
Published: October 23, 2018
Sativex® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial.
Journal: The International journal of neuroscience
Published: May 25, 2018
Efficacy, tolerability, and safety of an oral enzyme combination vs diclofenac in osteoarthritis of the knee: results of an individual patient-level pooled reanalysis of data from six randomized controlled trials.
Journal: Journal of pain research
Published: November 18, 2016
Last Updated: 09/26/2026